An unresectable Klatskin's tumor?

Gastroenterology. 2014 Jun;146(7):e3-4. doi: 10.1053/j.gastro.2014.01.011. Epub 2014 Apr 26.
No abstract available

Publication types

  • Case Reports
  • Video-Audio Media

MeSH terms

  • Aged, 80 and over
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage
  • Antigens, CD20 / analysis
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Bile Duct Neoplasms / diagnosis*
  • Bile Duct Neoplasms / pathology
  • Biomarkers, Tumor / analysis
  • Biopsy
  • Cholangiopancreatography, Endoscopic Retrograde
  • Cyclophosphamide / administration & dosage
  • Diagnosis, Differential
  • Doxorubicin / administration & dosage
  • Hepatic Duct, Common* / pathology
  • Humans
  • Klatskin Tumor / diagnosis*
  • Klatskin Tumor / pathology
  • Lymphoma, Large B-Cell, Diffuse / diagnosis*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / immunology
  • Lymphoma, Large B-Cell, Diffuse / pathology
  • Male
  • Neoplasm Staging
  • Predictive Value of Tests
  • Prednisone / administration & dosage
  • Rituximab
  • Treatment Outcome
  • Vincristine / administration & dosage

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Biomarkers, Tumor
  • R-CHOP protocol
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone